Aditya Kohli
Founder of Phathom Pharmaceuticals, Inc., Passage Bio, Inc., Scout Bio, Inc. and Recida Therapeutics, Inc., Aditya Kohli is an entrepreneur who currently holds the position of Chief Operating Officer & Director at HilleVax, Inc., Chief Business Officer for Phathom Pharmaceuticals, Inc. and Venture Partner at Frazier Management LLC. He is also on the board of Scout Bio, Inc. and Vice President for Frazier Life Sciences IX LP.
In the past Dr. Kohli held the position of Engagement Manager at McKinsey & Co., Inc.
He received an undergraduate degree and a graduate degree from Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
Transactions
Date
Transaction
Value
| 02/01/2023 | 85,466 | Award at $0 per share. | 0 |
